Added to YB: 2023-02-08
Pitch date: 2023-02-08
MRK [bullish]
Merck & Co., Inc.
+19.7%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
Market Cap
$280.2B
Pitch Price
$96.81
Price Target
N/A
Dividend
3.00%
EV/EBITDA
10.81
P/E
31.73
EV/Sales
4.92
Sector
Pharmaceuticals
Category
N/A
Show full summary:
MERCK & CO MRK
A summary for this pitch has not been created yet.
Read full article (0 min)